CD40 and cancer: To move forward our efforts for the development of CD40-targeting vaccines against cancer, we generated multiple recombinant proteins of humanized anti-CD40 antibody carrying different tumor-associated antigens (TAAs), including prostate-specific antigens and HPV16.E6/7 protein, as prototype vaccines.